Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7024)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2021 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maslennikov R, Ivashkin V, Efremova I, Alieva A, Kashuh E, Tsvetaeva E, Poluektova E, Shirokova E, Ivashkin K. Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis. World J Hepatol 2021; 13(5): 557-570 [PMID: 34131470 DOI: 10.4254/wjh.v13.i5.557] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v13/i5/557.htm |
| Number | Citing Articles |
| 1 |
Roman Maslennikov, Vladimir Ivashkin, Aliya Alieva, Elena Poluektova, Anna Kudryavtseva, George Krasnov, Maria Zharkova, Yuri Zharikov. Gut dysbiosis and body composition in cirrhosis. World Journal of Hepatology 2022; 14(6): 1210-1225 doi: 10.4254/wjh.v14.i6.1210
|
| 2 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Maria Zharkova, Oxana Zolnikova, Gyunay Bagieva, Vladimir Ivashkin. Presepsin as a biomarker of bacterial translocation and an indicator for the prescription of probiotics in cirrhosis. World Journal of Hepatology 2024; 16(5): 822-831 doi: 10.4254/wjh.v16.i5.822
Abstract(232) |
Core Tip(212) |
Full Article(HTML)(828)
|
Full Article with Cover (PDF)-3851K(48)
|
Audio-711K(16)
|
Peer-Review Report-226K(39)
|
Answering Reviewers-34K(25)
|
Supplementary Material-129K(28)
|
Full Article (PDF)-857K(52)
|
Full Article (XML)-134K(25)
|
Times Cited (1)
|
Total Visits (2309)
|
Open
|
| 3 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Probiotics in hepatology: An update. World Journal of Hepatology 2021; 13(9): 1154-1166 doi: 10.4254/wjh.v13.i9.1154
|
| 4 |
Irina Efremova, Roman Maslennikov, Oleg Medvedev, Anna Kudryavtseva, Anastasia Avdeeva, George Krasnov, Filipp Romanikhin, Mikhail Diatroptov, Maria Fedorova, Elena Poluektova, Anna Levshina, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis. Microorganisms 2024; 12(3): 463 doi: 10.3390/microorganisms12030463
|
| 5 |
Yurii O. Zharikov, Aida N. Gadzhiakhmedova, Yana V. Kiseleva, Roman V. Maslennikov, Aliya M. Aliyeva, Tatyana S. Zharikova, Vladimir N. Nikolenko. Somatotype and microbiome: trends and correlations in liver cirrhosis. Science and Innovations in Medicine 2024; 9(3): 164 doi: 10.35693/SIM630041
|
| 6 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?. World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
|
| 7 |
Kazuki Natsui, Atsunori Tsuchiya, Risa Imamiya, Mayuko Osada‐Oka, Yui Ishii, Yohei Koseki, Nobutaka Takeda, Kei Tomiyoshi, Fusako Yamazaki, Yuki Yoshida, Riuko Ohashi, Yiwei Ling, Koji Ueda, Nobuko Moritoki, Kazuhiro Sato, Takahiro Nakajima, Yoshinori Hasegawa, Shujiro Okuda, Shinsuke Shibata, Shuji Terai. Escherichia coli‐derived outer‐membrane vesicles induce immune activation and progression of cirrhosis in mice and humans. Liver International 2023; 43(5): 1126 doi: 10.1111/liv.15539
|
| 8 |
Kathrin Rothe, Tobias Bachfischer, Siranush Karapetyan, Alexander Hapfelmeier, Milena Wurst, Sabine Gleich, Karl Dichtl, Roland M. Schmid, Julian Triebelhorn, Laura Wagner, Johanna Erber, Florian Voit, Rainer Burgkart, Andreas Obermeier, Ulrich Seibold, Dirk H. Busch, Patrick C. Rämer, Christoph D. Spinner, Jochen Schneider, Florence Claude Doucet-Populaire. Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort. Microbiology Spectrum 2023; 11(6) doi: 10.1128/spectrum.02585-23
|
| 9 |
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525
|
| 10 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina Pervushova, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis. International Journal of Molecular Sciences 2024; 25(4): 1988 doi: 10.3390/ijms25041988
|
| 11 |
Masahide Enomoto, Hiroaki Takaya, Tadashi Namisaki, Yukihisa Fujinaga, Norihisa Nishimura, Yasuhiko Sawada, Kosuke Kaji, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Takashi Inoue, Masanori Matsumoto, Hitoshi Yoshiji. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis. Hepatology Research 2022; 52(4): 390 doi: 10.1111/hepr.13743
|
| 12 |
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
|
| 13 |
Ridda Manzoor, Weshah Ahmed, Nariman Afify, Mashal Memon, Maryam Yasin, Hamda Memon, Mohammad Rustom, Mohannad Al Akeel, Noora Alhajri. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022; 10(5): 1045 doi: 10.3390/microorganisms10051045
|
| 14 |
David Swilling, Ashini Patel, Arun B. Jesudian, Martin Laville, Ryan Hickey, Bedros Taslakian, Akhilesh K. Sista. Impact of Transjugular Intrahepatic Shunt Creation on the Gut Microbiota. Journal of Vascular and Interventional Radiology 2024; 35(3): 469 doi: 10.1016/j.jvir.2023.12.003
|
| 15 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Anna Kudryavtseva, George Krasnov. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World Journal of Gastroenterology 2022; 28(10): 1067-1077 doi: 10.3748/wjg.v28.i10.1067
|
| 16 |
Roman Maslennikov, Elena Poluektova, Oxana Zolnikova, Alla Sedova, Anastasia Kurbatova, Yulia Shulpekova, Natyia Dzhakhaya, Svetlana Kardasheva, Maria Nadinskaia, Elena Bueverova, Vladimir Nechaev, Anna Karchevskaya, Vladimir Ivashkin. Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis. International Journal of Molecular Sciences 2023; 24(22): 16502 doi: 10.3390/ijms242216502
|
| 17 |
Xinlu Cao, Oksana Zolnikova, Roman Maslennikov, Maria Reshetova, Elena Poluektova, Arina Bogacheva, Maria Zharkova, Vladimir Ivashkin. Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis. Metabolites 2023; 13(7): 859 doi: 10.3390/metabo13070859
|
| 18 |
Jian Wu, Mariza Bortolanza, Guanghua Zhai, Anquan Shang, Zongxin Ling, Bin Jiang, Xiaochen Shen, Yiwen Yao, Jiong Yu, Lanjuan Li, Hongcui Cao. Gut microbiota dysbiosis associated with plasma levels of Interferon‐γ and viral load in patients with acute hepatitis E infection. Journal of Medical Virology 2022; 94(2): 692 doi: 10.1002/jmv.27356
|
| 19 |
E. G. Malaeva, I. O. Stoma. Microbiota and Long-Term Prognosis in Liver Cirrhosis. The Russian Archives of Internal Medicine 2024; 14(3): 213 doi: 10.20514/2226-6704-2024-14-3-213-220
|
| 20 |
Irina Efremova, Aliya Alieva, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Yury Zharikov, Yaroslav Nerestyuk, Anna Karchevskaya, Vladimir Ivashkin. Akkermansia muciniphila is associated with normal muscle mass and Eggerthella is related with sarcopenia in cirrhosis. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1438897
|
| 21 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(649) |
Core Tip(579) |
Full Article(HTML)(3359)
|
Full Article with Cover (PDF)-2077K(111)
|
Full Article (Word)-351K(59)
|
Audio-395K(9)
|
Peer-Review Report-291K(64)
|
Answering Reviewers-97K(76)
|
Full Article (PDF)-967K(305)
|
Full Article (XML)-396K(80)
|
Times Cited (12)
|
Total Visits (7317)
|
Open
|
| 22 |
Yushan Bu, Yisuo Liu, Tai Zhang, Yinxue Liu, Zhe Zhang, Huaxi Yi. Bacteriocin-Producing Lactiplantibacillus plantarum YRL45 Enhances Intestinal Immunity and Regulates Gut Microbiota in Mice. Nutrients 2023; 15(15): 3437 doi: 10.3390/nu15153437
|
| 23 |
Zengrong Wu, Hejun Zhou, Deliang Liu, Feihong Deng. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1218552
|
| 24 |
Maria Reshetova, Pavel Markin, Svetlana Appolonova, Ismail Yunusov, Oksana Zolnikova, Elena Bueverova, Natiya Dzhakhaya, Maria Zharkova, Elena Poluektova, Roman Maslennikov, Vladimir Ivashkin. Tryptophan Metabolites in the Progression of Liver Diseases. Biomolecules 2024; 14(11): 1449 doi: 10.3390/biom14111449
|
| 25 |
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential. Dokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
|
| 26 |
Vladimir Ivashkin, Oleg Shifrin, Roman Maslennikov, Elena Poluektova, Alexander Korolev, Anna Kudryavtseva, George Krasnov, Nona Benuni, Giovanni Barbara. Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02690-x
|
| 27 |
André Pontes-Silva, André Luiz Lopes, Erika da Silva Maciel, Fernando Rodrigues Peixoto Quaresma, Almir Vieira Dibai-Filho. Human metabolism and body composition: prospects for novel studies. Nutrition Reviews 2023; 82(1): 5 doi: 10.1093/nutrit/nuad040
|
| 28 |
Mei‐Tong Nie, Pei‐Qin Wang, Pei‐Mei Shi, Xia‐Lu Hong, Xin Zhang, Baoyu Xiang, Menghui Zhang, Wei‐Fen Xie. Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis. Journal of Gastroenterology and Hepatology 2024; 39(4): 762 doi: 10.1111/jgh.16484
|
| 29 |
Trinity Gulliver, Melissa Hewett, Panagiotis Konstantopoulos, Lisa Tran, Evangeline Mantzioris. The neutropenic diet and its impacts on clinical, nutritional, and lifestyle outcomes for people with cancer: a scoping review. Journal of Nutritional Science 2024; 13 doi: 10.1017/jns.2024.61
|
| 30 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Elena Shirokova, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis. Microorganisms 2023; 11(9): 2202 doi: 10.3390/microorganisms11092202
|